DNAL1 Gene Primary Ciliary Dyskinesia Type 16 Genetic Test sale cost 4400 AED
FLNA Gene Otopaladigital Syndrome Type 1 Genetic Test sale cost 4400 AED FLNA Gene Otopaladigital Syndrome Type 1 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
DNAH9 Gene Primary Ciliary Dyskinesia DNAH9 Related Genetic Test sale cost 4400 AED DNAH9 Gene Primary Ciliary Dyskinesia DNAH9 Related Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

DNAL1 Gene Primary Ciliary Dyskinesia Type 16 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The DNAL1 Gene Primary Ciliary Dyskinesia Type 16 Genetic Test is a specialized diagnostic examination available at DNA Labs UAE, designed to identify mutations in the DNAL1 gene which are associated with Primary Ciliary Dyskinesia (PCD) Type 16. PCD is a rare, inherited disorder that affects the cilia, leading to issues with respiratory function, fertility, and other bodily systems. The test, costing 4400 AED, employs advanced genetic sequencing technologies to analyze the DNAL1 gene, providing essential information for the accurate diagnosis and management of this condition. This genetic test is crucial for individuals with a family history of PCD or those exhibiting symptoms, offering a pathway towards targeted treatment and improved quality of life.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DNAL1 Gene Primary Ciliary Dyskinesia Type 16 Genetic Test

At DNA Labs UAE, we offer the DNAL1 Gene Primary Ciliary Dyskinesia Type 16 Genetic Test. This test is designed to identify mutations or variations in the DNAL1 gene, which is associated with primary ciliary dyskinesia type 16 (PCD16). PCD16 is a rare genetic disorder characterized by abnormal ciliary function.

Test Details

The DNAL1 gene plays a crucial role in the movement of mucus and other substances in various organs, including the respiratory tract and reproductive system. Our Next-Generation Sequencing (NGS) technology allows us to analyze multiple genes simultaneously, providing valuable information about the presence of pathogenic variants in the DNAL1 gene.

Components and Price

The cost of the DNAL1 Gene Primary Ciliary Dyskinesia Type 16 Genetic Test is 4400.0 AED. The test can be performed using a blood sample, extracted DNA, or one drop of blood on an FTA card.

Report Delivery and Method

After the sample is collected, the report will be delivered within 3 to 4 weeks. The test is conducted using NGS technology, ensuring accurate and reliable results.

Test Type and Doctor

The DNAL1 Gene Primary Ciliary Dyskinesia Type 16 Genetic Test falls under the category of Ear Nose Throat Disorders. It is recommended to consult an ENT doctor for this test.

Test Department

Our Genetics department handles the DNAL1 Gene Primary Ciliary Dyskinesia Type 16 Genetic Test. Our team of experts is dedicated to providing accurate and comprehensive genetic testing services.

Pre Test Information

Prior to the test, it is important to provide the clinical history of the patient who is undergoing the PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by the PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN38.

Conclusion

The DNAL1 Gene Primary Ciliary Dyskinesia Type 16 Genetic Test is a valuable tool in diagnosing and managing PCD16. By analyzing the DNA sequence of the DNAL1 gene, this test provides important information about the presence of pathogenic variants, helping healthcare professionals make informed treatment decisions and offering genetic counseling to affected individuals and their families. Furthermore, the data obtained from this test contributes to the understanding of the underlying mechanisms of PCD16.

Test Name DNAL1 Gene Primary ciliary dyskinesia type 16 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN38
Test Details

The DNAL1 gene is associated with primary ciliary dyskinesia type 16 (PCD16), which is a rare genetic disorder characterized by abnormal ciliary function. Cilia are hair-like structures found on the surface of cells that play a crucial role in the movement of mucus and other substances in the respiratory tract, reproductive system, and other organs.

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously for the presence of genetic variants. In the context of PCD16, NGS genetic testing can be used to identify mutations or variations in the DNAL1 gene that may be causing the disorder.

By analyzing the DNA sequence of the DNAL1 gene, NGS genetic testing can provide valuable information about the presence of pathogenic variants, which can help in the diagnosis and management of PCD16. This information can be used to guide treatment decisions, provide genetic counseling to affected individuals and their families, and contribute to the understanding of the underlying mechanisms of the disorder.

SKU: TEST-2773 Category:

Related products